Found: 9
Select item for more details and to access through your institution.
Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2014, v. 7, p. 357, doi. 10.2147/PGPM.S53163
- By:
- Publication type:
- Article
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 4, p. 1180, doi. 10.1245/s10434-019-08099-9
- By:
- Publication type:
- Article
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 351, doi. 10.1093/oncolo/oyac266
- By:
- Publication type:
- Article
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 848, doi. 10.1634/theoncologist.2015-0522
- By:
- Publication type:
- Article
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 608, p. 1, doi. 10.1126/scitranslmed.abf5107
- By:
- Publication type:
- Article
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 6, p. 801, doi. 10.1111/pcmr.13179
- By:
- Publication type:
- Article
Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1.
- Published in:
- Pigment Cell & Melanoma Research, 2023, v. 36, n. 3/4, p. 314, doi. 10.1111/pcmr.13083
- By:
- Publication type:
- Article
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 23, p. 4393, doi. 10.1002/cncr.33812
- By:
- Publication type:
- Article
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article